XML 80 R31.htm IDEA: XBRL DOCUMENT v2.4.1.9
Summarized Quarterly Financial Information (Unaudited, in millions, except share data)
 12 Months Ended
Dec. 31, 2014
Quarterly Financial Information Disclosure [Abstract]  
Summarized Quarterly Financial Information (Unaudited, in millions, except share data)

Note 22 Summarized Quarterly Financial Information (Unaudited, in millions, except share data)

 

 

 

2014

 

 

 

First

 

 

Second

 

 

Third

 

 

Fourth

 

(In millions, except per share amounts)

 

Quarter(1)(2)

 

 

Quarter(1)(2)

 

 

Quarter(1)(2)

 

 

Quarter

 

Net sales

 

$

1,827.7

 

 

$

1,973.6

 

 

$

1,975.5

 

 

$

1,973.7

 

Gross profit

 

 

639.6

 

 

 

679.6

 

 

 

696.1

 

 

 

672.3

 

Net earnings from continuing operations

 

 

70.9

 

 

 

60.1

 

 

 

60.8

 

 

 

66.3

 

Net earnings from discontinued operations

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

Net earnings available to common stockholders

 

 

70.9

 

 

 

60.1

 

 

 

60.8

 

 

 

66.3

 

Basic net earnings per common share

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Continuing operations

 

$

0.34

 

 

$

0.28

 

 

$

0.29

 

 

$

0.31

 

Discontinued operations

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

Net earnings per common share—basic

 

$

0.34

 

 

$

0.28

 

 

$

0.29

 

 

$

0.31

 

Diluted net earnings per common share

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Continuing operations

 

$

0.33

 

 

$

0.28

 

 

$

0.28

 

 

$

0.31

 

Discontinued operations

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

Net earnings per common share—diluted

 

$

0.33

 

 

$

0.28

 

 

$

0.28

 

 

$

0.31

 

 

 

 

2013

 

 

 

First

 

 

Second

 

 

Third

 

 

Fourth

 

(In millions, except per share amounts)

 

Quarter(1)(2)

 

 

Quarter(1)(2)

 

 

Quarter(1)(2)

 

 

Quarter(1)(2)

 

Net sales

 

$

1,828.9

 

 

$

1,937.4

 

 

$

1,912.0

 

 

$

2,012.5

 

Gross profit

 

 

614.3

 

 

 

656.6

 

 

 

650.4

 

 

 

668.6

 

Net earnings from continuing operations

 

 

2.1

 

 

 

52.7

 

 

 

35.5

 

 

 

5.0

 

Net earnings from discontinued operations

 

 

2.0

 

 

 

2.0

 

 

 

2.5

 

 

 

24.0

 

Net earnings available to common stockholders

 

 

4.1

 

 

 

54.7

 

 

 

38.0

 

 

 

29.0

 

Basic net earnings per common share

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Continuing operations

 

$

0.01

 

 

$

0.27

 

 

$

0.18

 

 

$

0.03

 

Discontinued operations

 

 

0.01

 

 

 

0.01

 

 

 

0.01

 

 

 

0.12

 

Net earnings per common share—basic

 

$

0.02

 

 

$

0.28

 

 

$

0.19

 

 

$

0.15

 

Diluted net earnings per common share

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Continuing operations

 

$

0.01

 

 

$

0.24

 

 

$

0.17

 

 

$

0.02

 

Discontinued operations

 

 

0.01

 

 

 

0.01

 

 

 

0.01

 

 

 

0.11

 

Net earnings per common share—diluted

 

$

0.02

 

 

$

0.25

 

 

$

0.18

 

 

$

0.13

 

 

 

 

(1)

On December 6, 2013, we completed the sale of the rigid medical packaging business. On November 14, 2012, we completed the sale of Diversey Japan. Operating results for the rigid medical packaging business and Diversey Japan were reclassified to discontinued operations for the periods since the first quarter of 2012, and, accordingly, all prior period information has been revised. See Note 3, “Divestitures,” for further information about the sales.

(2)

Certain amounts have been revised to reflect the retrospective application of the Company’s change in inventory costing method for certain U.S. inventories to the FIFO method from the LIFO method. Refer to Note 2, “Summary of Significant Accounting Policies - Inventories,” of the notes to consolidated financial statements for further details surrounding this accounting policy change.